Your browser doesn't support javascript.
loading
The effects of empagliflozin on measured glomerular filtration rate and estimated extracellular and plasma volumes in patients with type 2 diabetes.
Jürgens, Mikkel; Schou, Morten; Hasbak, Philip; Kjaer, Andreas; Wolsk, Emil; Zerahn, Bo; Brandt-Jacobsen, Niels H; Gaede, Peter; Rossing, Peter; Faber, Jens; Inzucchi, Silvio E; Gustafsson, Finn; Kistorp, Caroline.
Afiliação
  • Jürgens M; Department of Endocrinology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
  • Schou M; Department of Endocrinology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark.
  • Hasbak P; Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark.
  • Kjaer A; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Wolsk E; Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Department of Biomedical Sciences, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
  • Zerahn B; Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Department of Biomedical Sciences, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
  • Brandt-Jacobsen NH; Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark.
  • Gaede P; Department of Cardiology, The Heart Centre, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
  • Rossing P; Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark.
  • Faber J; Department of Endocrinology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
  • Inzucchi SE; Slagelse Hospital, Slagelse, Denmark, University of Southern Denmark, Odense, Denmark.
  • Gustafsson F; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Kistorp C; Steno Diabetes Center Copenhagen, Herlev, Denmark.
Diabetes Obes Metab ; 25(10): 2888-2896, 2023 10.
Article em En | MEDLINE | ID: mdl-37395341

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Clinical_trials / Etiology_studies Limite: Humans Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Clinical_trials / Etiology_studies Limite: Humans Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Dinamarca